Benign Prostatic Hyperplasia
Open Access
- 1 May 1997
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 10 (5) , 349-366
- https://doi.org/10.2165/00002512-199710050-00004
Abstract
Symptomatic benign prostatic hyperplasia (BPH) is a common condition in older men and has a significant impact on their daily lives. Transurethral resection of the prostate (TURP) or open...Keywords
This publication has 94 references indexed in Scilit:
- Use of recombinant α1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophyPublished by Elsevier ,2003
- ??1-Blockers vs 5??-Reductase Inhibitors in Benign Prostatic HyperplasiaDrugs & Aging, 1995
- AlfuzosinDrugs, 1993
- Doxazosin Treatment in Patients with Prostatic ObstructionScandinavian Journal of Urology and Nephrology, 1993
- TerazosinDrugs & Aging, 1993
- Mortality and Reoperation after Open and Transurethral Resection of the Prostate for Benign Prostatic HyperplasiaNew England Journal of Medicine, 1989
- DoxazosinDrugs, 1988
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- Bladder Outflow Obstruction Treated with PhenoxybenzamineBritish Journal of Urology, 1982